Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia

被引：1

作者：

Gong, Zimu ^{[1
,2
]}

Xu, Mina L. ^{[3
]}

Chen, Mingyi ^{[4
]}

Cui, Wei ^{[5
]}

Kantarjian, Hagop M. ^{[6
]}

Cortes, Jorge E. ^{[6
]}

Zhou, Ting ^{[1
]}

Tang, Guilin ^{[1
]}

Wang, Wei ^{[1
]}

Medeiros, L. Jeffrey ^{[1
]}

Hu, Shimin ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, 1515 Holcombe Blvd,Unit 0072, Houston, TX 77030 USA

[2] AMITA Hlth St Joseph Hosp, Dept Internal Med, Chicago, IL USA

[3] Yale Univ, Dept Pathol, New Haven, CT USA

[4] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA

[5] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷 / 10期

关键词：

ABNORMALITIES; THERAPY;

D O I：

10.1002/ajh.25571

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E256 / E259

页数：4

共 10 条

[1] Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor
Inokura, Kyoko
Onishi, Yasushi
Shimosegawa, Kenji
Okitsu, Yoko
Katsuoka, Yuna
Fujiwara, Tohru
Fukuhara, Noriko
Ishizawa, Kenichi
Harigae, Hideo
[J]. ANNALS OF HEMATOLOGY, 2012, 91 (11) : 1825 - 1826
[2] Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment
Issa, Ghayas C.
Kantarjian, Hagop M.
Gonzalez, Graciela Nogueras
Borthakur, Gautam
Tang, Guilin
Wierda, William
Sasaki, Koji
Short, Nicholas J.
Ravandi, Farhad
Kadia, Tapan
Patel, Keyur
Luthra, Raja
Ferrajoli, Alessandra
Garcia-Manero, Guillermo
Rios, Mary Beth
Dellasala, Sara
Jabbour, Elias
Cortes, Jorge E.
[J]. BLOOD, 2017, 130 (19) : 2084 - 2091
[3] Jaitly Vanya, 2015, Stem Cell Investig, V2, P13, DOI 10.3978/j.issn.2306-9759.2015.06.01
[4] Imatinib mesylate (ST1571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase
Kantarjian, HM
Cortes, J
O'Brien, S
Giles, FJ
Albitar, M
Rios, MB
Shan, JQ
Faderl, S
Garcia-Manero, G
Thomas, DA
Resta, D
Talpaz, M
[J]. BLOOD, 2002, 99 (10) : 3547 - 3553
[5] Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia
Kovitz, Craig
Kantarjian, Hagop
Garcia-Manero, Guillermo
Abruzzo, Lynne V.
Cortes, Jorge
[J]. BLOOD, 2006, 108 (08) : 2811 - 2813
[6] A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML
Krysiak, K.
Christopher, M. J.
Skidmore, Z. L.
Demeter, R. T.
Magrini, V.
Kunisaki, J.
O'Laughlin, M.
Duncavage, E. J.
Miller, C. A.
Ozenberger, B. A.
Griffith, M.
Wartman, L. D.
Griffith, O. L.
[J]. BLOOD CANCER JOURNAL, 2016, 6 : e413 - e413
[7] Philadelphia chromosome-negative acute promyelocytic leukemia manifesting after long-term imatinib treatment for chronic myeloid leukemia: a case report and literature review
Morita, Kiyomi
Koya, Junji
Toya, Takashi
Nakamura, Fumihiko
Kurokawa, Mineo
[J]. ANNALS OF HEMATOLOGY, 2018, 97 (06) : 1105 - 1109
[8] Pitini Vincenzo, 2009, Leuk Res, V33, pe143, DOI 10.1016/j.leukres.2009.04.012
[9] Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy
Quintas-Cardama, A.
Kantarjian, H.
Abruzzo, L. V.
Cortes, J.
[J]. LEUKEMIA, 2007, 21 (11) : 2394 - 2396
[10] Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia in Blast Phase After 2 Years of Follow-Up in a Phase 3 Study Efficacy and Tolerability of 140 Milligrams Once Daily and 70 Milligrams Twice Daily
Saglio, Giuseppe
Hochhaus, Andreas
Goh, Yeow Tee
Masszi, Tamas
Pasquini, Ricardo
Maloisel, Frederic
Erben, Philipp
Cortes, Jorge
Paquette, Ronald
Bradley-Garelik, M. Brigid
Zhu, Chao
Dombret, Herve
[J]. CANCER, 2010, 116 (16) : 3852 - 3861

← 1 →